...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain
【24h】

High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain

机译:固定组合的高剂量羟考酮/纳洛酮延长释放:慢性癌疼痛患者的疗效和耐受性

获取原文
获取原文并翻译 | 示例

摘要

Opioids are associated with side effects in the treatment of moderate-to-severe chronic cancer pain. Oral combination of opioid agonist-antagonist oxycodone-naloxone (OXN-PR) attenuates gastrointestinal side effects; however, evidence on high-dose OXN-PR treatment is scant. This study evaluates the efficacy and tolerability of high-dose OXN-PR in chronic cancer pain.
机译:阿片类药物与治疗中度至严重的慢性癌痛的副作用有关。 阿片类Agonist-拮抗剂羟考酮 - 纳洛酮(OXN-PR)的口服组合衰减胃肠道副作用; 然而,关于高剂量牛粪治疗的证据是味道。 本研究评估了高剂量牛粪在慢性癌痛中的疗效和耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号